Excipient: Super Refined™ Polysorbate 20

Excipient: Super Refined™ Polysorbate 20
Product Description

Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to reduce API interaction and degradation. The benefits of Super Refined Polysorbates over standard pharmaceutical polysorbates include: • Better API stability and finished formulation integrity • Reduced potential for cellular irritation • Improved taste profile when used in oral liquid dosage forms

Chemical Description

  • Polysorbate 20
Pharmacopoeia Compliance
  • FDA-IID Listed
  • JP
  • PhEur
  • USP/NF
Chemical Group
  • Ester
  • Polysorbate
  • Sorbitan ester
Administration Route
  • Auricular
  • Nasal
  • Ophthalmic
  • Oral
  • Parenteral
  • Rectal and Vaginal
  • Topical
Functions
  • Emulsifier
  • Plasticiser
  • Solubiliser
  • Wetting agent
Market Application
  • Human Pharmaceutical
  • Veterinary Health
Physical Form
  • Clear, essentially colourless liquid

Read more Show less

Croda pharma

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    9005-64-5
  • Supplied from
    United States
More specifications Fewer specifications
Sales Markets
Show more Show less

Croda pharma

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company
View company profile

More Products from Croda pharma (26)

  • Bioprocessing solutions and excipients for protein therapeutic formulations

    Product Bioprocessing solutions and excipients for protein therapeutic formulations

    From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween...
  • Excipients for Consumer Health

    Product Excipients for Consumer Health

    Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
    Our excipient solutions support ...
  • High purity excipients for small molecule delivery

    Product High purity excipients for small molecule delivery

    We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le...
  • Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
    We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv...
  • Excipient: Super Refined™ PEG 400

    Product Excipient: Super Refined™ PEG 400

    Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, reducing excipi...
  • Excipient: Super Refined™ Polysorbate 80

    Product Excipient: Super Refined™ Polysorbate 80

    Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red...
  • Vaccine Adjuvant: Alhydrogel™

    Product Vaccine Adjuvant: Alhydrogel™

    • Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines • The gel is a suspension of boehmite-like (aluminium oxyhydroxide) hydrated nano/micron size crystals in loose aggregates • The products have v...
  • Excipient: Super Refined™ DEGEE

    Product Excipient: Super Refined™ DEGEE

    Super Refined DEGEE is ideal for use in topical and transdermal applications to enhance the permeation of poorly water-soluble API’s through various layers of the skin, thereby improving drug delivery. It can also be used as a co-solvent in self-emulsifying drug delivery systems (SEDDS), or self-microe...
  • Excipient: Super Refined™ P35 Caster Oil

    Product Excipient: Super Refined™ P35 Caster Oil

    Super Refined P35 Castor Oil is a castor oil derivative, resulting from the reaction of glycerol ricinoleate and 35 mols of ethylene oxide. This product is a liquid nonionic solubiliser and emulsifier, characteristic of a slightly yellow hue, and is intended for use in parenteral, ophthalmic, oral, and...
  • Vaccine Adjuvant: Quil-A™

    Product Vaccine Adjuvant: Quil-A™

    • Quil-A is a highly purified and concentrated saponin adjuvant purified from bark extract of the Quillaja saponaria Molina tree which has been specifically developed for use as an adjuvant in vaccines • Quil-A saponin was originally purified and characterised by Dr. Pharm • Kristian Dalsgaard in 1...
  • Cholesterol

    Product Cholesterol

    W/O emulsifier, emulsion stabiliser and moisturiser with skin conditioning and barrier repair benefits. High purity grade also available. Recommended topical usage levels of 0.5-5%. Cholesterol in the free and combined state is the most widely occurring sterol in animal tissue. It is an essential compound ...
  • Crodafos™ CES pharma

    Product Crodafos™ CES pharma

    Phosphate-based emulsifying and conditioning wax that produces stable thixotropic O/W emulsions, allowing rapid active release and localised delivery of active to the skin. The formation of lamellar liquid crystal oleosomes mean that Crodafos CES-based emulsions offer greater versatility compared to more c...
show all 26 other products

Croda pharma resources (2)

  • Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

    News Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

    Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. 
    22 Aug 2023
  • Addressing the challenges of vaccine formulation

    Brochure Addressing the challenges of vaccine formulation

    To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of. 

    Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.